David A. Porter Consulting
[Consultation Services,
Resume, Publications,
and Presentations are described
in detail below]
Common Concerns
- Do you find yourself facing an audit by a regulatory agency?
- Are you certain that you have validated/verified
compendial-related procedures?
- Are you sure you have performed the validation of your
alternative methods with correct statistics?
- Is you GLP laboratory fully compliant?
- Do you find yourself in need of a custom training program,
but you don't have a training department at your company?
- Have you encountered strange results/problems of a
microbiological nature?
- Are your laboratory SOPs as good as they can be?
- Do you find yourself in a constant state of firefighting
instead of productive research and development?
- Do you feel as though you are part of a fully interactive
team, or does your company behave as though you are in your
individual departmental silos?
If any of the concerns above apply to you and your company, David
Porter may be able to help. He has been involved in achieving
successful resolutions to each of the issues raised above.
If you would like to contact David Porter regarding possible
consultation about any of the issues, please click the link below.
Contact David Porter
Dr. Porter is at heart an educator. At one time, he was a
certified public school teacher, and taught for two years before
returning to school to earn his Ph.D.
He has employed his educator nature throughout all of his
industrial work and on into his consulting career. What this
means to those he works with is:
- He strives not merely to impart knowledge, but to teach
others how to teach themselves
- He uses any of a number of approaches, separately or in
combination, to accomplish the teaching goals
- He treats each person with respect, because we can also
serve as each other's teachers and students
- He views learning as a cooperative venture, with two-way
information exchange between student and teacher essential
- He accomplishes his teaching goals efficiently with both the
student's goals and the student's institutional goals in mind
What this all translates to is regardless of the issue at hand,
those he works with will come to better understand how to resolve
their current issue, how to deal with similar issues, and how to
teach themselves more effectively in the future. This will
translate into better trained individuals who will also work better
as team members because the interactiveness of the learning process
will be emphasized through word and deed.
DAVID A. PORTER
Senior Director, Training
Summary of Qualifications
Proven change agent and leader in technical
problem solving with over 18 years experience in compendial
activities, medical device, consumer product and pharmaceutical
industry research, development and management.
Combining a broad technical background in life sciences,
biostatistics, and computer acumen, with an innate ability to
recognize and develop strengths in people, I help develop and
strengthen individuals and organizations.
Professional Experience
Senior
Director, Training - Vectech Pharmaceutical Consultants
For all of my clients, I have brought my
education-based approach into play. I do not consider myself
to be the font of all knowledge. Rather, I believe that by
working with the client together we will arrive at the resolution of
your issue(s).
Director General Policies
and Requirements Division -
United States
Pharmacopeia
- As Director of the General Policies
and Requirements division at USP, I oversaw the activities of 9
scientific liaisons responsible for 10 Expert Committees.
These committees were in turn responsible for the vast
majority of the general chapters within the USP/NF.
There were also a number of
monographs
within the domain of some of the Expert Committees.
- As Director of the division, I was also responsible for the
development of the divisional annual budget, tracking activities
of all division members, giving presentations to numerous groups
outside of USP, coauthoring journal articles and book chapters,
setting up divisional meetings, report preparation, etc.
- I was the team leader for an
interdepartmental team that developed a new process facilitating the
generation of more general chapters at a faster rate with higher
quality.
- I served as the Project Manager for
the development of software that incorporated a large database and
presented an attractive graphical user interface encompassing
Information and Standards Development (ISD), Sales and Marketing,
and Reference Standards information.
The project entailed interaction with Information Technology,
Sales and Marketing, ISD, and Reference Standards personnel. The
database developed as part of this project served as the core
database for a new infrastructure project (in which I also
participated) that impacts the standards revision process.
I was also a co-project manager for the development of a new
electronic workflow system for use by the Drug Standards Division
and the Publication group at USP.
- I served as an instructor in the USP
Training program with emphasis on the development and teaching of
courses related to microbiology/biology as related to the USP.
I was the lead developer of the course content for the
Fundamentals of Microbiology course.
When requested, I also participate in the teaching of the
introductory courses (USP 100 and 101).
I also participated in the development of the course material
for those two courses,
- My leadership experience includes the
management of numerous industrial life science and biostatistics
groups, including up to 25 individuals ranging from technical to
senior scientist levels.
I effectively developed individuals and teams within the
various departments, and assured that the departmental financial
aspects were well planned and tracked.\
- Trained in Total Quality Management,
Targeted Management, Managing Quality Improvement, Team Dynamics, cGLP, cGMP, cGCP, ISO 9001.
Served as an in-house ISO auditor, and performed outside GLP
audits of contract facilities.
- Designed statistical protocols for
numerous clinical studies as required for medical device studies.
Protocols ensured that sample sizes were adequate,
randomization assured, appropriate statistical methods included, and
data properly collected and entered into the database.
Wrote reports of clinical outcomes, and made presentations to
both technical and non-technical people.
- Developed computerized databases
(programmed in Java) for use in tracking activities related to USP
Expert Committees and associated documentation.
- Created united department with
uniform SOP's/systems from four pre-existing sections (in compliance
with cGLP, ISO 9001).
- Participated on cross-functional
teams that successfully registered flagship products internationally
(Europe,
Japan).
- Performed nonparametric analysis of
historical clinical data leading to new claim for duration of skin
moisturization for marketed product.
Taught in-house regulatory people as to the basis of the
statistical approach.
Manager of Biochemistry and Life
Sciences -
Revlon
Research
Center
-
Led the matrix team that developed
screens (incorporating statistical assessments), resulting in two
patented concepts for new nail and skin treatment products.
Manager, Microbiology, Toxicology,
Biostatistics (separate groups)
- Bausch & Lomb, Inc
-
Restructured microbiology functions
to coincide with the industrial organization’s changing strategic
plans. Created uniform
departmental SOP's/systems from four pre-existing sections (in
compliance with cGLP, ISO 9001).
-
Strengthened
interaction/communication between the biology departments and all
others within R&D and the divisional marketing groups for the
industrial organization.
-
Built and developed an industrial
department that created and statistically validated a rapid,
reproducible, high throughput multiparameter cytotoxicity test
battery (3 new procedures published). Numerous products were
developed, and technical issues resolved (pharmaceutical and medical
device products) using these methods.
Education
-
Post-doctoral fellow,
Ohio
State
University,
Case
Western Reserve
University
-
Ph.D. Zoology,
University
of
California at
Berkeley
-
MS Biology,
University
of
North Dakota
-
BS Biology, cum laude, departmental
honors,
Beloit
College
Publications/Patents
- Dabbah, R. and Porter, D.A.
(2004). The role of USP in the Microbiological Assessment of
Parenteral Manufacturing.
In Microbial Contamination Control in Parenteral
Manufacturing (Kevin L. Williams,
Ed.), Marcel Dekker, Inc.
- Fivizzani, A.J. and Porter, D.A.
(1984). Seasonal
variation in the effect of thermal stimulation on reproduction in
two species of Fundulus.
In Chronobiology 1982-1983.
15th International Conference of the International
Society for Chronobiology
(E. Haus and H.F. Kabat, Eds.), S. Karger Publishers, Inc.
- Foster, D.N.,
Galehouse, D., Giordano, T., Min, B., Lamb, I.C., Porter,
D.A., Intehar, K.J. and Bacon, W.L.
(1992). Nucleotide sequence of the cDNA encoding the common
a subunit of the chicken pituitary glycoprotein
hormones. J. Mole.
Endocrinol. 8: 21-27.
- Gracia-Navarro, F., Gracia-Navarro
S., Porter, D.A. and Licht, P.
(1989). Immunocytochemical and ultrastructural study of the frog (Rana
pipiens) pars distalis with special reference to folliculo-stellate
cell function during in
vitro superfusion. Cell
and Tissue Res. 256: 623-630.
- Gracia-Navarro, F., Porter, D.,
Malag”n, MM and Licht, P. (1990).
Stereological study of gonadotropes in the frog Rana pipiens
after GnRH stimulation in vitro.
Cell and Tissue Res. 262: 171-176.
- Hamberger, J.F., Porter, D.A. and
Jessee, C.B. (1995).
Monitoring cellular metabolism in L929 mouse fibroblasts
using a D-Glucose consumption assay.
In Vit. Toxicol. 8: 239-246.
- Hamberger, J.F., Root, C.A and
Porter, D.A. (1992).
The relative toxicity of five common disinfecting/preserving
agents as determined by a modified neutral red dye release assay and
the agar overlay technique.
ICLC 19: 130-135.
- Licht, P, Khorrami-Yaghoobi, P. and
Porter, D.A. (1985). Effects of gonadectomy and steroid treatment on plasma gonadotropins
and the response of superfused pituitaries to gonadotropin releasing
hormone (GnRH) in the turtle Sternotherus odoratus.
Gen. Comp. Endocrinol. 60: 441-449.
- Licht, P. and Porter, D.A.
(1985). LH
secretion in response to gonadotropin releasing hormone (GnRH) by
superfused pituitaries from two species of turtles.
Gen. Comp. Endocrinol. 59: 442-448.
- Licht, P. and Porter, D.A.
(1985). In vivo
and in vitro responses to gonadotropin releasing hormone in the
turtle, Chrysemys picta, in relation to sex and reproductive stage.
Gen. Comp. Endocrinol. 60: 75-85.
- Licht, P. and Porter, D.A.
(1986). Role of
gonadotropin-releasing hormone in regulation of gonadotropin
secretion from amphibian and reptilian pituitaries.
In: Hormones and Reproduction in Fishes, Amphibians and
Reptiles (D. Norris and R.E. Jones, Eds.).
Plenum Press,
New York.
- Licht, P., Porter, D.A. and Millar,
R.P. (1987).
Specificity of amphibian and reptilian pituitaries for
various forms of gonadotropin-releasing hormones in vitro.
Gen. Comp. Endocrinol. 66: 248-255.
- Pappa, H., Porter, D.A., and Russo,
K.A. (2006).
Development of a New USP General Information Chapter:
Validation of Compendial Procedures.
Pharm. Tech. 30(3): 164-169.
- Porter, D.A.
(1985). The
effects of cycloheximide on in vitro response of Rana pipiens
pituitaries to continuously superfused gonadotropin-releasing
hormone. Biol. Reprod.
33: 393-400.
- Porter, D.A. (2007). Review of USP microbiology
chapters. PDA Letter XLIII(2): pp 1, 13-16.
-
Porter, D.A. (2007). Review of USP chapter
<1223> Validation of Alternative Microbiological Methods
presented at the 2007 Global Conference on Pharmaceutical
Microbiology. Amer. Pharm. Rev. 10(3) 76-81.
-
Porter, D.A. (2007)
Qualification, Validation, and
Verification. Pharm. Tech. April, 2007.
-
Porter, D.A. (co-inventor,1999
patent). Compositions
for application to keratinous substrates and a method for
strengthening such substrates.
U.S.
Patent #5,993,837.
- Porter, D.A. (co-inventor, Methods
for treating skin with 3-hydroxy benzoic acid and related
compositions.
U.S.
Patent #6,235,297.
- Porter, D.A. and Fivizzani, A.J.
(1983). Spontaneous occurrence of a synchronous hermaphrodite in the banded
killifish, Fundulus diaphanus (Lesueur).
J. Fish. Biol. 22: 671-675.
- Porter, D.A. and Licht, P.
(1985). Pituitary responsiveness to superfused GnRH in two species of ranid
frogs. Gen. Comp.
Endocrinol. 59: 308-315.
- Porter, D.A. and Licht, P.
(1986). Effects
of temperature and mode of delivery on responses to gonadotropin-releasing
hormone by superfused frog pituitaries.
Gen. Comp. Endocrinol. 63: 236-244.
- Porter, D.A. and Licht, P.
(1986). Dependence of GnRH action on Na+, K+, and Ca++
in the frog, Rana pipiens, pituitary.
J. Exp. Zool. 239: 379-391.
- Porter, D.A. and Licht, P.
(1986). The
cellular basis of the calcium dependence of GnRH-stimulated
gonadotropin release from frog, Rana pipiens, pituitaries.
J. Exp. Zool. 240:
353-361
-
Porter, D.A., Sutton, S.V.W, Dabbah,
R. and Knapp, J.E. (2002).
Developing an
information chapter in the USP to demonstrate equivalency in
microbiological methods.
Amer. Pharm. Rev. 5(2): 14-19.
- Schepper-Vaughan, J. and Porter, D.A.
(1993). A new in
vitro method for assessing the potential toxicity of soft contact
lens care solutions. The CLAO Journal 19: 54-57.
- Sutton, S.V.W., Franco, R.J., Porter,
D.A., Mowrey-McKee, M.F.,
Busschaert,
S.C., Hamberger, J.F. and Proud, D.W.
(1991). D-value
determinations are an inappropriate measure of disinfecting activity
of common contact lens disinfecting solutions.
Appl. Environ. Microbiol.
57: 2021-2026.
- Sutton, S.V.W., Knapp,
J.E. and Porter, D.A. (2005). Activities of the USP
Analytical Microbiology expert committee during the 2000-2005
revision cycle. PDA J. Sci. Tech. 59(3): 157-176.
- Sutton, S.V.W. and Porter,
D.A. (2003). Development of the Antimicrobial Effectiveness Test
as USP Chapter <51>. PDA J. Sci. Tech. 56(6): 300-311.
- Sutton, S.V.W.
and Porter, D.A. (2007).
Compounding of sterile medications in the pharmacy.
Contol. Environ. 10(6): 11-13.
- Tirumalai, R. and Porter, D. (2005).
Terminal Sterilization and Potential for Parametric Release.
American Pharmaceutical Review 8(4): 26-31.
Oral Presentations
(partial list)
-
Current Activities of the USP Analytical Microbiology
COE
-
AAI,
Philadelphia,
2001
-
Current Initiatives of the USP Analytical Microbiology
COE
-Microbiological Control Conference, 2001
-
Harmonization of Pharmacopeial Biotechnology Products Testing
- AAPS, Denver 2001
-
Current Initiatives of the USP Analytical Microbiology
COE
- Sanofi Synthelabo
Conference, 2002
-
Current Initiatives of the USP Analytical Microbiology
COE
- Pfizer Global Microbiology Forum (after dinner presentation), 2002
-
Equivalency of Microbiology Methods
-
Philadelphia,
2002
-
Highlights of the May 2002 PDA/USP Joint Conference on Sterile
Product Manufacturing
-
AAI,
2002
-
Highlights of the May 2002 PDA/USP Joint Conference on Sterile
Product Manufacturing
- PDA audioconference, 2002
-
Sterility Assurance-The USP Perspective
- American Association of Tissue Banks, 2002
-
USP Standards for Biotech Drugs
- National Association of Boards of Pharmacy, 2002
-
Validation of Microbiological Methods
- PDA meeting,
New Orleans,
2002
-
Microbiological Controls: Compendial Tests and Harmonization
- AAPS workshop, 2003
-
Proposed USP Chapter <1072> “Disinfectants and Antiseptics”
- DMPQ, 2003
-
Regulatory and Pharmacopeial Issues for Rapid Microbiological
Methods
- A3P
Canada
Conference on Applied Microbiology, 2003
-
Validation of Alternative Microbiological Methods
- Barnett meeting, 2003
-
Validation of Microbiological Methods
- RMUG, 2003
-
Harmonization Status of
Microbiology-Related Chapters
-
IBI,
San Diego,
2004
-
Method Validations. What Happens When It’s not
Equivalent, and Concerns with Method Validations
RMUG
presentation, 2004
-
Presentation for Microbiology Laboratory Controls Seminar addressing
USP <1072.
FDA, 2004
-
Recent Initiatives of the USP Analytical Microbiology Expert
Committee.
Presentation for High Peaks Associates workshop, 2004
-
USP Microbiology Update
– January 2004.
Elite Microsource Corporation,
Puerto Rico
-
USP Microbiology Update
– October 2004 - Presentation for Microrite course
-
USP Microbiology Update
- Microbiology Seminar, CDER, FDA, 2004
-
USP Microbiology Update
- Micro Users Group, Wyeth, (after dinner presentation), 2004
-
Rapid Microbiological Methods
- a USP Perspective - PDA-Milan, 2005
-
USP Issues and Updates
- NJPQCA, 2005
-
Utility of Chapters <87> and <88> in USP 28
- PDA Forum, 2005
-
Validation Versus Verification. Vectech
Webinar - November, 2006
-
Validation of Alternative Microbiological Methods -
February 2007 -
PMF Open Conference on Compendial Issues
-
Validation of Alternative Microbiological Methods - June
2007 - High Peaks Associates Validation Conference
-
Basic Statistics for Microbiologists, Part 1 - June 2007 -
High Peaks Associates Validation Conference
-
Basic Statistics for Microbiologists, Part 2 - June 2007 -
High Peaks Associates Validation Conference
-
Demonstration of Equivalence - June 2007 - High Peaks
Associates Validation Conference